DiNuzzo Private Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$123K Sell
489
-1
-0.2% -$215 0.01% 95
2026
Q1
$107K Hold
490
0.01% 100
2025
Q4
$112K Sell
490
-6
-1% -$1.37K 0.01% 98
2025
Q3
$104K Hold
496
0.01% 100
2025
Q2
$92.1K Sell
496
-1
-0.2% -$186 0.01% 105
2025
Q1
$104K Sell
497
-2
-0.4% -$389 0.01% 99
2024
Q4
$88.7K Sell
499
-1
-0.2% -$184 0.01% 111
2024
Q3
$98.8K Buy
500
+241
+93% +$45K 0.01% 104
2024
Q2
$44.5K Sell
259
-26
-9% -$4.31K 0.01% 103
2024
Q1
$52K Hold
285
0.01% 94
2023
Q4
$44.2K Buy
+285
New +$41.5K 0.01% 101

Other funds holding ABBV

DiNuzzo Private Wealth's ABBV Position: Q2 2026 in Review

DiNuzzo Private Wealth reduced its AbbVie (ABBV) stake by 0.2% in Q2 2026, selling an estimated $215 and leaving 489 shares worth $123K. The position accounts for 0.01% of the portfolio, ranked #95.

DiNuzzo Private Wealth first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 1,743 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • DiNuzzo Private Wealth held 489 shares of AbbVie worth $123K as of Q2 2026.
  • DiNuzzo Private Wealth sold 1 AbbVie share in Q2 2026, an estimated $215.
  • AbbVie made up 0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #95 holding.
  • DiNuzzo Private Wealth first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 1,743 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.